SecBot SecBot

TWST

Twist Bioscience Corp
Nasdaq· Biological Products, (No Diagnostic Substances)· Inc. DE· CIK 0001581280 Biotech & Drug DiscoveryGenomics & Gene Editing
$105.40 −6.20 (−5.56%)
Nov 16 4:00 PM ET · prev $111.60
Market cap
$7.6B
Mid cap
Consensus
Buy
74% Buy or better · 19 analysts
Median target
🔒 Subscribers only
1 year
+298.3%
from $26.46 · Nov 17
30 days
−20.6%
from $132.75
52-week range
$25.45–205.00
−49% from high · low Nov 19
Avg volume 20D
2.43M
shares / day
Short interest
9.84M
≈14.8% of shares · −3.6%
Days to cover
4.3
at average volume
Insider net
−$79.6M
0 buyers · 6 sellers · since Sep 17
New fund stakes
6
Q2 2026 13F · 3 exits
Reddit crowd
64°
Warm · 3 mentions this week
SecBot read MIXED 22 reports · 90 days
Balance 3 bearish · 1 bullish · 18 neutral oldest → newest, height = score
Avg score ·High conf. 13/22

Price

Daily candles with volume. Callouts mark insider and congressional trades, rating changes, 13F stakes, reports, catalysts, court and regulator actions, Reddit spikes and short-interest jumps. Hover one for the details (tap on phones).

Signal stack

Where each data set points today.

  • InsidersBEARISH

    6 insiders sold $79.6M.

  • InstitutionsBULLISH

    Q2 2026: 49 added (6 new), 30 trimmed or exited. Largest new: Fil $66.0M, Marshall Wace $40.8M.

  • AnalystsBULLISH

    14 of 19 rate it Buy or better.

  • Short sellersSTEADY

    Short interest −3.6% to 9.84M shares. 4.3 days to cover, ≈14.8% of shares.

  • TrendDOWNTREND

    30% below its 50-day average.

  • SocialQUIET

    Crowd 64° (warm) this week from 3 mentions: 2 bullish, 0 bearish. No setup is alerting.

Who's buying

13F· Q2 2026
6
new positions
3
exits
$184.8M
in new stakes
FundMoveSharesValue
FMR LLCDOUBLED4,703,044$483.8M
ARK Investment Management LLCTRIM4,549,803$468.1M
PRICE T ROWE ASSOCIATES INC /MD/DOUBLED3,634,652$373.9M
EdgePoint Investment Group Inc.TRIM2,521,635$259.4M
WILLIAM BLAIR INVESTMENT MANAGEMENT, LLCTRIM2,174,594$223.7M
FARALLON CAPITAL MANAGEMENT, L.L.C.ADD2,136,400$219.8M
MORGAN STANLEYDOUBLED1,189,861$122.4M
D. E. Shaw & Co., Inc.DOUBLED1,185,605$122.0M

Quarterly 13F filings are due 45 days after each quarter ends.

The Street

19 analysts
Buy 74% rate it Buy or better
Strong Buy7Buy7Hold4Sell1Strong Sell0

Fresh Price Targets

Analyst price targets updated within the last 24 hours are for subscribers only.

Subscribe for Full Access
Recent actions
DateFirmActionRating
Nov 16, 2026🔒 Fresh data, subscribers only
MAINTAIN
MAINTAIN
Nov 13, 2026Leerink Partners
MAINTAIN
MAINTAINOutperform
Nov 13, 2026TD Cowen
MAINTAIN
MAINTAINBuy
Nov 13, 2026Canaccord Genuity
MAINTAIN
MAINTAINBuy
Nov 13, 2026Baird
MAINTAIN
MAINTAINOutperform
Oct 13, 2026TD Cowen
MAINTAIN
MAINTAINBuy

Washington

Corporate Lobbying

8 lobbying filings and 4 bills this company lobbies on, with spend, stage and how each bill touches it, are for subscribers.

Subscribe for Full Access

Insider ledger

Form 4
$0
bought · 0 insiders
$79.6M
sold · 6 insiders
DateInsiderTypeValue
Nov 3, 2026
WERNER ROBERT F.
Chief Accounting Officer
Nov 3, 2026
SELL$20.0K
Nov 3, 2026
Cho Dennis
See Remarks
Nov 3, 2026
SELL$128.5K
Nov 3, 2026
Finn Patrick John
President and COO
Nov 3, 2026
SELL$347.3K
Nov 3, 2026
Leproust Emily M.
Chief Executive Officer
Nov 3, 2026
SELL$619.2K
Nov 3, 2026
Green Paula
SVP of Human Resources
Nov 3, 2026
SELL$136.3K
Oct 23, 2026
Finn Patrick John
President and COO
Oct 23, 2026
SELL$302.2K
Oct 9, 2026
Laponis Adam
Chief Financial Officer
Oct 9, 2026
SELL$384.8K
Oct 5, 2026
Leproust Emily M.
Chief Executive Officer
Oct 5, 2026
SELL$88.0K

Earnings setup

Estimates

Revision history: 🔒 Fresh data, subscribers only

PeriodEPS est.Range30D rev.Revenue
Current Q🔒 Fresh data, subscribers only
Next Q🔒 Fresh data, subscribers only
Current FY🔒 Fresh data, subscribers only
Next FY🔒 Fresh data, subscribers only
Catalysts
Scheduled dates and disclosed events: earnings, FDA and trial readouts, halts, press releases. Colored dot = impact.
Recent

Short side

FINRA· Oct 30, 2026
9,835,760
shares short
-3.6%
vs prior settlement
4.3
days to cover
≈14.8%
of shares outstanding
Recent activity
The latest filings, insider trades, analyst actions, press and options flow, newest first.
Nov 16, 2026 SEC
🔒 Fresh report (last 24h), subscribers only
Nov 16, 2026 SEC
🔒 Fresh report (last 24h), subscribers only
Nov 12, 2026 SEC
Twist Bioscience reported fiscal Q4 2026 revenue of $126.6M (+28% YoY), above the $123.6M consensus, and achieved…
8-K · Impact 6/10
Nov 12, 2026 Earnings result
TWST Q4 2026 Earnings: EPS $-0.32 (+14.6% vs est)
Nov 3, 2026 Insider
WERNER ROBERT F. sold 148 shares
Chief Accounting Officer @ $135.40 ($20.0K)
Nov 3, 2026 Insider
Cho Dennis sold 949 shares
See Remarks @ $135.40 ($128.5K)
Nov 3, 2026 Insider
Finn Patrick John sold 2,565 shares
President and COO @ $135.40 ($347.3K)
Jun 30, 2026 Inst.
FMR LLC · DOUBLED
4,703,044 shares ($483.8M)
Reddit Mentions per day, 14 days
Crowd this week 64° Warm 2 bullish · 0 bearish
Mentions, 7 days 3 0 in posts · 3 in comments
Recent comments
All social signals and their track records

SecBot reports

44 filings · 3 bullish · 9 bearish · 32 neutral
All TWST filing & press-release reports (44)